Releases - RaySearch Laboratories

View:

2010

 

Found press releases

 

RaySearch Laboratories AB (publ) Interim Report January 1 – September 30, 2010

11/12/2010 1:45 AM EST
JANUARY 1 – SEPTEMBER 30, 2010

· Net sales for the period totaled SEK 83.0 M (47.3)
· Operating profit totaled SEK 24.5 M (17.1)
· Profit after tax amounted to SEK 17.5 M (12.6) and earnings per share to SEK 0.51 (0.37)
· Cash flow was a negative SEK 2.8 M (pos: 5.4)
· RaySearch received FDA approval for RayStation® in the US in March
· The collaboration agreement with Varian was expanded in...

Massachusetts General Hospital in Boston chooses RaySearch’s treatment planning ...

10/29/2010 3:53 AM EST
Massachusetts General Hospital (MGH) in Boston, USA, has selected RaySearch’s treatment planning system RayStation® as their next generation planning software for delivery of IMRT and VMAT treatments.

In 2008, RaySearch and MGH entered into a long-term research and development collaboration within the field of multi-criteria optimization for radiation therapy. In all radiation treatments, the clinician has to...

RaySearch Laboratories AB (publ) Interim Report January 1 – June 30, 2010

8/27/2010 1:45 AM EST
JANUARY 1 – JUNE 30, 2010

· Net sales for the period totaled SEK 60.9 M (34.7)
· Operating profit totaled SEK 23.8 M (16.6)
· Profit after tax amounted to SEK 17.4 M (12.3), corresponding to earnings per share of SEK 0.51 (0.36)
· Cash flow amounted to SEK 2.1 M (1.8)
· RaySearch received FDA 510(k) clearance for RayStation® in the US in March
· The collaboration agreement with Varian was expanded in...

Resolutions at the Annual General Meeting of RaySearch Laboratories AB (publ)

5/25/2010 2:26 PM EST
The Annual General Meeting of the shareholders of RaySearch Laboratories AB (publ), which was held on May 25, 2010, passed the following resolutions, among others.
The proposal by the Board of Directors and the Managing Director concerning a distribution of dividends amounting to fifty (50) öre per share was adopted. May 28, 2010, was chosen as record day in respect of the dividends, and thus payment of the...

RaySearch Laboratories AB (publ) Interim Report January 1 – March 31, 2010

5/11/2010 1:45 AM EST
JANUARY 1 – MARCH 31, 2010
• Net sales for the period totaled SEK 28.1 M (16.9)
• Profit after tax was SEK 8.2 M (7.3), corresponding to earnings per share of SEK 0.24 (0.21)
• Operating profit totaled SEK 11.2 M (9.9)
• Cash flow was a negative SEK 1.8 M (positive: 8.7)
• RaySearch received FDA 510(k) clearance for RayStation® in the US

SIGNIFICANT EVENTS AFTER THE CLOSE OF THE PERIOD
• The collaboration...

RaySearch and Varian Medical Systems expand strategic collaboration

5/3/2010 3:15 AM EST
RaySearch Laboratories AB (publ) announces today that the license agreement with Varian Medical Systems has been restructured to add one new product, strengthen the collaborative product development efforts, and make it easier to add new capabilities and features to Varian’s Eclipse™ treatment planning system. Eclipse software currently incorporates three RaySearch developments, including tools for biological...

RaySearch’s 2009 Annual Report Published

4/30/2010 3:30 AM EST
As of today, the 2009 Annual Report of RaySearch Laboratories AB (publ) is available in Swedish as a pdf file on the company’s website www.raysearchlabs.com. The printed version in Swedish is now under distribution to the shareholders. The English version is under production and will be finalized in conjunction with RaySearch´s Annual General Meeting on Tuesday, May 25, 2010. Printed annual reports can be ordered...

Invitation to Annual General Meeting 2010

4/22/2010 10:49 AM EST
The shareholders in RaySearch Laboratories AB (publ) are hereby invited to the Annual General Meeting on Tuesday, 25 May, 2010 at 6:00 p.m., in Kammarsalen at the Berns Conference Center, Berzelii Park, Stockholm, Sweden.

NOTICE, ETC.

Shareholders who wish to participate in the Annual General Meeting, must:

- be recorded in the share register maintained by Eucroclear Sweden AB (Euroclear) not later than...

RaySearch receives 510(k) clearance for RayStation

3/17/2010 4:00 AM EST
RaySearch Laboratories AB (publ) has received FDA 510(k) clearance for its RayStation® treatment planning system.

RayStation® is RaySearch’s proprietary complete treatment planning system that integrates all RaySearch’s advanced treatment planning solutions into one flexible system. It includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization, highly accurate dose engines...

RaySearch Laboratories AB (publ) Year-end Report 2009

2/18/2010 1:45 AM EST
JANUARY 1 – DECEMBER 31, 2009
• Net sales for the period amounted to SEK 83.7 M (62.7)
• Profit after tax totaled SEK 30.1 M (18.2) and earnings per share amounted to SEK 0.88 (0.53)
• Operating profit totaled SEK 40.9 M (21.1)
• Cash flow amounted to SEK 9.4 M (neg: 8.5)
• A breakthrough order for a proton treatment planning system was secured in June
• The new VMAT product from the collaboration with Philips...

RaySearch Laboratories

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are sold through license agreements with leading partners su...

View more


  CONTACT